Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Vasc Interv Radiol. 2011 Nov 12;23(1):116–121. doi: 10.1016/j.jvir.2011.10.001

Figure 3.

Figure 3

Infarct volume at 4 hours vs. dodecafluoropentane emulsion (DDFPe) treatment time. Categorization of treatment times to model various clinical scenarios, pre-treatment, hyperacute, and acute therapy, demonstrates improved outcomes compared to control. Whether DDFPe is used as a pre-treatment (30 minutes before embolization), a hyperacute treatment (0 to 30 minutes), or an acute treatment (1 to 3 hours), stroke volumes are significantly reduced. *P≤0.021, Dunnett-adjusted comparison of ranks.